Join Versiti for these presentation and poster viewing highlights at ISTH today, Sunday June 22
Sunday, June 22, 2025
Join Versiti for these presentation highlights:
9:30 AM - 10:45 AM EDT
OC 17 - Joint health in hemophilia: Biomarkers
OC 17.3 - Type-I interferon promotes NETs-dependent joint damage in Hemophilia.
Location: 145 A&B
12:15 PM - 1:00 PM EDT
CD 03 - Systems hematology: The What, How and Why
Speaker: Lisa Baumann Kreuziger, MD, Blood Research Institute, Versiti Blood Center of Wisconsin
Location: Howard University Room, Marriott Marquis Washington, D.C.
2:45 PM - 4:00 PM EDT
OC 20 - Novel therapies in hemophilia - Clinical trials I
OC 20.5 - Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children: XTEND-ed Second Interim Analysis
Presenter: Lynn Malec, MD,MSc, Versiti Comprehensive Center for Bleeding Disorders, Medical College of Wisconsin
Location: Ballroom A-C
OC 23 - Novel hemostatic agents
OC 23.3 - Therapeutic efficacy of a novel anti-ADAMTS13 antibody to treat acquired von Willebrand syndrome
Oral Communication Co-Author: Joshua Muia, PhD, Versiti Blood Research Institute
Location: 207 A&B
OC 24 - Bringing DOACs to pediatrics: A new frontier in thrombosis treatment
OC 24.4 - Real-World Data on DOAC Use in Children: An Update from the International Throm-PED DOAC-Registry
Oral Communication Co-Author: Brian Branchford, MD, Versiti Medical Sciences Institute, Medical College of Wisconsin
Location: 152 A&B
OC 25 - Cardiovascular mechanisms and outcomes
OC 25.4 - The Circulating Tissue Factor-Platelet Axis in the Pathogenesis of Pulmonary Arterial Thrombosis
Location: 151 A&B
OC 27 - Biology of VWF/ADAMTS13 II
OC 27.2 - Essential Role of VWF-aIIbß3 Binding in Thrombus Stability in Vessel Injury (3:00 PM - 3:15 PM)
Location: 145 A&B
OC 28 - Genomics and transcriptomics in hemostasis
OC 28.3 - Furthering Understanding of VWF Copy Number Variants in Patients with von Willebrand Disease (3:15 PM - 3:30 PM)
Presenter Anna Patricia Miller, PhD, Co-Authors Jacquelyn D Riley, MS, CGC, Kenneth Friedman, MD, Stefanie N Dugan, MS, CGC, Versiti Diagnostic Laboratories
Location: 201
Versiti Poster Viewing Sessions
1:45-2:45 | PNS 01
Location: Exhibition Hall D & E
PB0063 - Elevated vWF despite high ADAMTS13 in Kenyan SCD Cohort with vaso-occlusion and ischemic stroke
PB0075 - Identification of Protein-Protein Interaction Between ADAMTS13 and Activated Platelet Marker CD63
PB0086 - Large scale unbiased proteomics uncovers novel pathways and biomarkers for VWD Type 1
PB0259 - Using mRNA lipid nanoparticles to reverse PAI-1 deficiency in blood